Search results

Back

COMMON QUESTIONS

90% of our funding comes from individual donors. Learn how you can support MSF’s lifesaving care with a gift.

DONATE Menu
Scroll down for content

News & stories

Get the latest news, stories, videos, and more from our medical humanitarian projects around the world.

MSF staff mobilize for Gaza in front of the Parliament in Bern, Switzerland.

World leaders must act now to respond to genocide in Gaza

News Sep 17, 2025

Stop the genocide. Let Gaza live. Sign the petition.

MSF USA staff, medical aid workers, and supporters gather in front of UN headquarters in New York during the September 2025 session of the General Assembly to call on world leaders to take urgent action to stop the genocide in Gaza.

News Sep 12, 2025

Doctors Without Borders USA names Tirana Hassan as new CEO

Tirana Hassan

story Sep 19, 2025

How conflict, displacement, and corporate decisions impact diabetes care

Tawfik has to take insulin every day in addition to around six other pills to help control his diabetes and hypertension.

story Sep 19, 2025

Alarming surge of cholera cases in northwestern Burundi

Medical staff treat cholera patients in Burundi.

Speaking out about the emergencies our staff and patients witness is part of who we are. Explore our history and principles.

News & stories

5 results

Story | Sep 18, 2023

The long and winding road to affordable access to a key TB drug

Christophe Perrin, the MSF Access Campaign‘s TB advocacy pharmacist, discusses the need for secure affordable access to improved TB medicines.

Read more
An MSF doctor in India looks at an X-ray of a lung.

News | Sep 12, 2023

J&J and Cepheid must expand access to TB drug and tests

TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools

Read more
A patient sits at a table in front of an MSF staff member for a free X-ray at an MSF tuberculosis (TB) screening sites in Manila.

Story | Jul 13, 2023

Johnson & Johnson deal falls short for people with TB

Johnson & Johnson must end its patent monopoly on bedaquiline so generic versions of this lifesaving drug can be widely produced.

Read more
A woman in a green headscarf and her young daughter are treated for drug resistant tuberculosis at MSF’s treatment center in Kandahar, Afghanistan.

News | Apr 26, 2023

J&J must stop blocking generic versions of lifesaving TB drug

J&J’s patent monopoly continues to keep bedaquiline out of reach.

Read more
Screening session for TB

News | Mar 23, 2023

MSF applauds rejection of J&J attempt to extend TB drug patent

The rejection of the salt form of bedaquiline is welcome news for people with drug-resistant tuberculosis.

Read more
Mirror of a woman wearing a surgical face mask in Mumbai, India.

Filters

Clear all
Country
Medical issues
Content type
Publish date
For Donation Inquiries 
See donor options here. 
 
U.S. Media Inquiries 
Reach out to the press team. 
 
Non-U.S. Media Inquiries 
Contact the MSF office in your country/territory.
For Donation Inquiries 
See donor options here. 
 
U.S. Media Inquiries 
Reach out to the press team. 
 
Non-U.S. Media Inquiries 
Contact the MSF office in your country/territory.

Support our work where it’s needed most.

Your unrestricted gifts enable us to provide lifesaving medical humanitarian care on the ground and speak out about what we see.

Donate

© Médecins Sans Frontières 2025 Federal tax ID#: 13-3433452

Unrestricted donations enable MSF to carry out our programs around the world. If we cannot honor a specific request, we will reallocate your donation to where the needs are greatest.

© Médecins Sans Frontières 2025 Federal tax ID#: 13-3433452

Unrestricted donations enable MSF to carry out our programs around the world. If we cannot honor a specific request, we will reallocate your donation to where the needs are greatest.

We speak out. Get updates.

How we use funds

Your gift helps us provide medical humanitarian aid for hundreds of thousands of people each year.

Learn more

84%

Programs

15%

Fundraising

1%

Management & General Admin

MSF